Literature DB >> 2567255

HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.

D M Robinson1, S Holbeck, J Palmer, G T Nepom.   

Abstract

The HLA class II-related susceptibility to type I insulin-dependent diabetes mellitus (IDDM) is examined in 94 multiplex families sorted by the presence or absence of a DR4+ haplotype in at least one diabetic family member. The families with DR4+ haplotypes are then sorted by the presence or absence of a DR4-linked DQ beta 3.2 allele. Further analysis assumes each multiplex family to represent a single diabetic genetic event and identifies the HLA class II haplotype(s) present in all affected members. The DQ beta 3.2 allele is present in over 95% of the multiplex families where DR4+ haplotypes segregate with IDDM, implying a major permissive role in determining susceptibility to IDDM.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567255     DOI: 10.1002/gepi.1370060128

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  5 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  Genetic analysis of susceptibility to type 1 diabetes.

Authors:  J A Todd
Journal:  Springer Semin Immunopathol       Date:  1992

Review 3.  A functional framework for interpretation of genetic associations in T1D.

Authors:  Gerald T Nepom; Jane H Buckner
Journal:  Curr Opin Immunol       Date:  2012-07-26       Impact factor: 7.486

4.  The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese.

Authors:  J A Todd; Y Fukui; T Kitagawa; T Sasazuki
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition.

Authors:  W W Kwok; E Mickelson; S Masewicz; E C Milner; J Hansen; G T Nepom
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.